MedAvail Holdings, Inc. Common Stock
MDVL
MDVL was delisted on the 12th of February, 2024.
38 hedge funds and large institutions have $92.8M invested in MedAvail Holdings, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 8 increasing their positions, 11 reducing their positions, and 18 closing their positions.
1,551% more call options, than puts
Call options by funds: $2.81M | Put options by funds: $170K
209% more capital invested
Capital invested by funds: $30M → $92.8M (+$62.8M)
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
22% less funds holding
Funds holding: 49 → 38 (-11)
27% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 11
50% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 18
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RG
Redmile Group
San Francisco,
California
|
+$24.8M |
| 2 |
AWGLSCP
ABG-WTT Global Life Science Capital Partners
Central, Hong Kong,
Hong Kong
|
+$19.6M |
| 3 |
ABG
Ally Bridge Group
New York
|
+$5.22M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$971K |
| 5 |
Millennium Management
New York
|
+$236K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$649K |
| 2 |
DM
Deerfield Management
New York
|
-$537K |
| 3 |
State Street
Boston,
Massachusetts
|
-$205K |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$149K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$77K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
Bank of America
Charlotte,
North Carolina
| – | -$3.07K | -35 | -92% |
|
52
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$2.19K | -25 | -89% |
|
53
Group One Trading
Chicago,
Illinois
| – | -$1.75K | -20 | Closed |
|
|
AIP
54
Ameritas Investment Partners
Lincoln,
Nebraska
| – | -$1K | -18 | Closed |
|
55
Simplex Trading
Chicago,
Illinois
| – | -$1.49K | -17 | Closed |
|
MDVL Hedge Fund Activity: Q2 2022 in Review
38 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in MedAvail Holdings, Inc. Common Stock (MDVL) for Q2 2022, worth a combined $92.8M — up 209% from $30M a quarter earlier.
Sellers outnumbered buyers: 18 funds closed out of MDVL and 9 opened new positions — a net loss of 9 holders — while 11 trimmed existing stakes and 8 added.
The largest buyer was Redmile Group, adding an estimated $24.8M. The largest seller was BlackRock, cutting an estimated $649K.
- 38 institutional investors held MedAvail Holdings, Inc. Common Stock (MDVL) as of Q2 2022, down from 49 in Q1 2022.
- Funds reported $92.8M of MedAvail Holdings, Inc. Common Stock stock for Q2 2022, up 209% quarter-over-quarter.
- 9 funds opened new MedAvail Holdings, Inc. Common Stock positions in Q2 2022 and 18 closed out, a net change of -9 holders.
- The largest MedAvail Holdings, Inc. Common Stock buyer in Q2 2022 was Redmile Group, an estimated $24.8M added.
- The largest MedAvail Holdings, Inc. Common Stock seller in Q2 2022 was BlackRock, an estimated $649K sold.
Based on aggregated 13F filings for Q2 2022.